Rating History for Telomir Pharma (TELO) by Rodman & Renshaw
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/13/2026 | Michael King Jr. | New Coverage | Buy (N/A) |
8.00 (N/A) |
1.35 (1.25) |
-7.41% | Details |
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/13/2026 | Michael King Jr. | New Coverage | Buy (N/A) |
8.00 (N/A) |
1.35 (1.25) |
-7.41% | Details |
![]() |
|||||||